IVERSON GENETIC DIAGNOSTICS INC

Profile

Company Names

IVERSON GENETIC DIAGNOSTICS INC

Addresses

401 TERRY AVENUE NORTH, SEATTLE, WA 98109

19805 NORTH CREEK PARKWAY, BOTHELL, WA 98011

19805 NORTH CREEK PARKWAY, SUITE 200, BOTHELL, WA 98011

19805 NORTH CREEK PKWY, SUITE 200, BOTHELL, WA 98011

Phone Numbers

206-946-6000
425-318-1332

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

WASHINGTON

Total Amount Raised:

$863,500.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2014-10-07 
$20,000.00 
$5,000,000.00 
$4,980,000.00 
Debt 
7
2012-11-01 
$42,500.00 
$1,000,000.00 
$957,500.00 
Equity 
6
2011-11-30 
$50,000.00 
$2,000,000.00 
$1,950,000.00 
Debt 
5
2011-11-01 
$115,000.00 
$2,000,000.00 
$1,885,000.00 
Debt 
4
2011-07-18 
$75,000.00 
$9,000,000.00 
$8,925,000.00 
Equity 
3
2010-04-28 
$110,000.00 
$8,000,000.00 
$7,890,000.00 
Equity 
2
2010-03-09 
$110,000.00 
$3,000,000.00 
$2,890,000.00 
Debt 
1
2009-11-25 
$341,000.00 
$700,000.00 
$359,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
DUBAY 
DIRECTOR
FRANK 
 
ECOCK 
DIRECTOR
FRANK 
R. 
ECOCK 
DIRECTOR
DAVID 
MICHAELS 
DIRECTOR
JEFF 
 
NYWEIDE 
EXECUTIVE OFFICER
BOB 
 
QUILLINAN 
EXECUTIVE OFFICER
DORANNE 
 
SATTERLEE 
EXECUTIVE OFFICER, DIRECTOR
HARVEY 
 
SCHILLER 
DIRECTOR
YELENA 
 
SHEVELENKO 
EXECUTIVE OFFICER
THOMAS 
SIGGIA 
DIRECTOR
TOM 
 
SIGGIA 
DIRECTOR
DEAN 
 
SPROLES 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-10-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE
NONE
NONE
EMERGENT FINANCIAL GROUP, INC.